Search

Your search keyword '"Shmuel Odes"' showing total 10 results
Start Over Author "Shmuel Odes" Publisher elsevier bv
10 results on '"Shmuel Odes"'

1. PGI49 CHANGES IN HEALTH RELATED QUALITY OF LIFE IN CROHN'S DISEASE PATIENTS FOLLOWING MINDFULNESS-BASED COGNITIVE INTERVENTION: PRELIMINARY RESULTS OF A RANDOMIZED CONTROLLED TRIAL

Author

Shmuel Odes, Michael Friger, Ganit Goren, Vered Slonim-Nevo, Dagan Schwartz, Dan Greenberg, Orly Sarid, and Ruslan Sergienko

Subjects
Health related quality of life, medicine.medical_specialty, Cognitive Intervention, Crohn's disease, Mindfulness, business.industry, Health Policy, Public Health, Environmental and Occupational Health, medicine.disease, law.invention, Randomized controlled trial, law, Physical therapy, medicine, business
Published
2019
Full Text
View/download PDF

2. P095 PSYCHOLOGICAL DISTRESS IN PATIENTS WITH CROHN'S DISEASE: A CROSS-SECTIONAL STUDY USING THE BRIEF SYMPTOM INVENTORY INSTRUMENT

Author

Doron Schwartz, Dan Greenberg, Orly Sarid, Shmuel Odes, Vered Slonim-Nevo, Michael Friger, and Ruslan Sergienko

Subjects
Crohn's disease, Hepatology, business.industry, Cross-sectional study, Gastroenterology, medicine, Immunology and Allergy, Psychological distress, In patient, medicine.disease, business, Clinical psychology
Published
2018
Full Text
View/download PDF

3. Budesonide versus prednisone in the treatment of active Crohn's disease

Author

Raphael Bruck, Simon Bar Meir, Menachem Moshkovitz, Ulrich Mittmann, Alexandra Lavy, Yehuda Chowers, Ron Reshef, Rami Eliakim, Eran Maoz, Shmuel Odes, Amos Sternberg, Dov Abramovitch, and Georges Leichtmann

Subjects
Budesonide, medicine.medical_specialty, Crohn's disease, Chemotherapy, Hepatology, medicine.drug_class, business.industry, medicine.medical_treatment, Gastroenterology, medicine.disease, Crohn's Disease Activity Index, Surgery, law.invention, Clinical trial, Randomized controlled trial, law, Prednisone, Internal medicine, medicine, Corticosteroid, business, medicine.drug
Abstract

Background & Aims: Budesonide (BUD) is a potent steroid that undergoes extensive first-pass metabolism. BUD incorporated in a pH-dependent formulation has been proposed as an alternative treatment for Crohn's disease (CD). The aim of this study was to compare the efficacy and safety of BUD and prednisone (PRED) in the treatment of active CD involving the terminal ileum and/or the colon. Methods: Patients with mild to moderately active CD were included in a randomized, double-blind, double-dummy controlled trial. Patients received either 9 mg BUD once daily for 8 weeks or 40 mg PRED once daily for the first 2 weeks tapered gradually to 5 mg/day by the end of the study. Disease activity, quality of life, and laboratory parameters were recorded. Results: One hundred patients received BUD, and 101 patients received PRED. By intention-to-treat analysis, treatment efficacy defined as Crohn's Disease Activity Index of GASTROENTEROLOGY 1998;115:835-840

Published
1998
Full Text
View/download PDF

4. Healthcare Costs of Inflammatory Bowel Disease in The Biologic Era: A Study Of 2,451 Patients with Twelve years Follow-Up Evaluation

Author

Elena Chernin, Shmuel Odes, Orly Sarid, Michael Friger, Dagan Schwartz, Vered Slonim-Nevo, Hillel Vardi, and Dan Greenberg

Subjects
Follow up evaluation, medicine.medical_specialty, business.industry, Health Policy, Health care, Public Health, Environmental and Occupational Health, medicine, Intensive care medicine, business, medicine.disease, Inflammatory bowel disease, Surgery
Published
2016
Full Text
View/download PDF

5. The Impact of Inflammatory Bowel Disease on Work Productivity: Comparison of A Real-World Sample Of Patients With Crohn's Disease And Ulcerative Colitis

Author

Vered Slonim-Nevo, Shmuel Odes, Michael Friger, H Vardy, Orly Sarid, A Katz Avitan, Dagan Schwartz, and Dan Greenberg

Subjects
Work productivity, medicine.medical_specialty, Crohn's disease, business.industry, Health Policy, Public Health, Environmental and Occupational Health, Sample (statistics), medicine.disease, Inflammatory bowel disease, Gastroenterology, Ulcerative colitis, 03 medical and health sciences, 0302 clinical medicine, 030220 oncology & carcinogenesis, Internal medicine, medicine, 030211 gastroenterology & hepatology, business
Published
2016
Full Text
View/download PDF

6. Healthcare costs of a consecutive cohort of patients with Ulcerative Colitis and Crohn’s disease treated at a Tertiary Medical Center in Israel

Author

Dagan Schwartz, Vered Slonim-Nevo, Shmuel Odes, Michael Friger, Orly Sarid, Hillel Vardi, and Dan Greenberg

Subjects
medicine.medical_specialty, Crohn's disease, business.industry, Health Policy, Public Health, Environmental and Occupational Health, medicine.disease, Ulcerative colitis, Surgery, Internal medicine, Health care, Cohort, medicine, Center (algebra and category theory), business
Published
2015
Full Text
View/download PDF

8. Associations Between Crohn's Disease Severity And Specific Socio-Demographic, Quality-Of-Life And Coping Factors

Author

Nava Gaspar, Michael Friger, D. Munteau, A. Moshkelo, Freha N. Abu, Alex Rozental, Vered Slonim-Nevo, Yaakov G. Ben, Alexander Fich, Shmuel Odes, Vitaly Dizengof, Doron Schwartz, Krugliak P, Leslie Eidelman, Orly Sarid, Hillel Vardi, and Dan Greenberg

Subjects
Coping (psychology), Crohn's disease, Health Policy, Socio demographics, Public Health, Environmental and Occupational Health, medicine, medicine.disease, Psychology, Clinical psychology
Published
2014
Full Text
View/download PDF

9. The month of birth is linked to the risk of developing Crohn's disease but not ulcerative colitis in the Israeli Jewish population

Author

Benjamin Avidan, Shmuel Odes, Simon Bar-Meir, Yehuda Chowers, and Rami Eliakim

Subjects
education.field_of_study, Pediatrics, medicine.medical_specialty, Crohn's disease, Hepatology, Month of birth, business.industry, Judaism, Population, Gastroenterology, medicine.disease, Ulcerative colitis, medicine, education, business
Published
2003
Full Text
View/download PDF

10. Passive smoking in patients with inflammatory bowel disease — an Israeli multicenter case control study

Author

Aharon Halak, Efratt Broide, Rami Eliakim, Alexandra Lavy, Julian Paz, Tuvia Gilet, Shmuel Odes, Yishai Run, D. Keter, Yael Villa, Alexander Fich, Shimon Reif, and Yaron Niv

Subjects
medicine.medical_specialty, Passive smoking, Hepatology, business.industry, Gastroenterology, Case-control study, medicine.disease, medicine.disease_cause, Inflammatory bowel disease, Surgery, Internal medicine, medicine, In patient, business
Published
2000
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results